Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Institutional Investors Approve of SEC’s Shareholder Proxy Changes

I'd like to see that happen.

7
Aug 24, 2010 03:45PM
5
Aug 24, 2010 04:14PM
11
Aug 24, 2010 04:16PM
12
Aug 24, 2010 05:42PM
7
Aug 24, 2010 07:09PM
Share
New Message
Please login to post a reply